One company's production of a popular bladder cancer therapy is set to halt by mid-2017, generating worries from patients and oncologists that there will be a shortage. The production of Bacillus ...

Amid a global drug shortage, thousands of patients with bladder cancer are unable to receive their recommended treatment each year. While Merck has pledged to make as many doses as it can, the company ...

Sanofi Pasteur said it’s discontinuing the manufacture of TheraCys, an important bladder cancer drug, and shortages are expected, while the US Food and Drug Administration (FDA) on Friday released ...

Sanofi SA plans to stop producing a bladder-cancer treatment that was in short supply for several years, saying it hasn’t been able to restore full production at a Toronto manufacturing plant that had ...